Login
Israel-Hamas Conflict
World Cup
Social Media
Boxing
Military
War
Benjamin Netanyahu
South America
Artificial Intelligence
Donald Trump
Natural Disasters
Immigration
Instagram
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

psychedelicalpha.com image

News from psychedelicalpha.com

We’ve assigned a media bias rating of unknown to psychedelicalpha.com. You can read more about our methodology here.
If you want to know if psychedelicalpha.com is credible or reliable, look no further. We rank psychedelicalpha.com as Unknown factuality. Find out more about our methodology here.

Information about psychedelicalpha.com

Where is psychedelicalpha.com located?psychedelicalpha.com's Website

Media Bias Ratings

Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.

Factuality

Learn more about  Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about  Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top psychedelicalpha.com News

Texas Invests $50 Million in Ibogaine Research for Addiction Treatment, Advocates Still Eye Tri-State
Psychedelic Drugs · Austin

Texas Invests $50 Million in Ibogaine Research for Addiction Treatment, Advocates Still Eye Tri-State

72% Center coverage: 18 sources
Texas has launched the largest publicly funded research initiative for ibogaine, investing $50 million to study the plant-based psychoactive compound as a potential breakthrough treatment for addiction. Bryan Hubbard, Executive Director of the American Ibogaine Initiative, successfully advocated for the Texas program after facing resistance in other states, including Kentucky."Making sure that folks understand what ibogaine is, what it does, and…See the Story
atai Life Sciences and Beckley Psytech to Combine Creating a Global Leader in Psychedelic ...
Psychedelic Drugs

atai Life Sciences and Beckley Psytech to Combine Creating a Global Leader in Psychedelic ...

100% Center coverage: 4 sources
Strategic combination establishes a market-leading mental health company with a pipeline that includes potentially transformative, rapid-acting psychedelic assets differentiated by their convenient route of administration and short time-in-clinicCombined company will operate under the name atai Beckley with a joint leadership…See the Story
A New Psychedelic Era Dawns in America
Parkinson's Disease

A New Psychedelic Era Dawns in America

100% Center coverage: 1 sources
Magic mushrooms remain illegal in California but you wouldn’t know that from the gatherings in San FranciscoSee the Story

May 2025 Psychedelic Patent Update: Gilgamesh Broadens Moat Around Lead Candidate Following Positive Phase 2a Readout; Lykos Publishes Further Continuation Applications; Reconnect Joins Crowded 5-MeO-DMT Patent Landscape - Psychedelic Alpha

Written by Psychedelic Alpha’s Noah Smith with support from Editor-at-Large and patent attorney Graham Pechenik of Calyx Law. The Psychedelic Patent Update provides headline figures and data regarding published psychedelic patent applications and grants, as well as a brief summary of a select handful of patent-related actions. In this Issue: *** We added 17 PCTs and 34 U.S. SourceRead Article

Pα+ Psychedelic Bulletin #200: Can Czechia Deliver on Psilocybin Access? A Closer Look at ‘atai Beckley’; Q1’25 Psychedelic Lobbying Update; Catching Up with the Class of Bulletin #100 - Psychedelic Alpha

The Class of Bulletin #100: Where Are They Now? • Can Czechia Deliver on Psilocybin Access and Provide a Model for the Continent? • A Closer Look at atai’s Potential Acquisition of Beckley Psytech • Q1’25 Psychedelic Lobbying Update • Holy Trips and Hot Takes: Religious Leaders Study Finally Published • and much, much more…Czechia · CzechiaRead Article

Pα+ Psychedelic Bulletin #199: Lykos Takeover Nears Completion; Fewer than 100 Patients Received Psychedelics in Australia During First 18 Months of Access; Ibogaine Bill Clears Texas Legislature Amid THC Crackdown - Psychedelic Alpha

A deal that would see a fresh shot of capital injected into MDMA drug developer Lykos Therapeutics is nearing completion, with insiders saying the first phase of the deal could close any day soon. According to information obtained by Psychedelic Alpha, the initial $50 million tranche will be split evenly between Elon Musk ally Antonio Gracias and ‘Europe’s most feared… SourcePsychedelic Drugs · AustraliaRead Article

Can a State Fast-Track a Psychedelic Breakthrough? Inside Texas’ Plan to Fund Ibogaine Trials - Psychedelic Alpha

Texas is on the verge of launching the largest publicly funded psychedelic research initiative in U.S. history: a $50 million public-private partnership to support FDA-approvable ibogaine trials. The initiative has drawn support from high-profile figures like Rick Perry, but also concerns over safety, cost, access, and the lack of recognition for Indigenous knowledge. We take a look at the bold… SourceAustin, Texas · AustinRead Article

Dopamine Type-1 Receptor Binding in Major Depressive Disorder Assessed Using Positron Emission Tomography and [11C]NNC-112

100% Center coverage: 3 sources
The dopamine type-1 receptor has been implicated in major depressive disorder (MDD) by clinical and preclinical evidence from neuroimaging, post mortem, and behavioral studies. To date, however, selective in vivo assessment of D1 receptors has been limited to the striatum in MDD samples manifesting anger attacks. We employed the PET radioligand, [11C]NNC-112, to selectively assess D1 receptor binding in extrastriatal and striatal regions in a mo…Psychedelic DrugsSee the Story

Lawyer Who Sued Federal Health Agency Over Marijuana Rescheduling Will Now Work There, With Focus On Psychedelics

Coverage: 2 sources
An attorney with a history of suing top federal agencies in pursuit of marijuana and psychedelics reform and government transparency is joining the Trump administration, serving under U.S. Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. as deputy general counsel, Marijuana Moment has learned. Matthew Zorn—who is well known for taking HHS and the Drug Enforcement Administration (DEA) to court under both the Biden and…Robert F. Kennedy Jr. · WashingtonSee the Story

Pα+ Psychedelic Bulletin #198: New Data Offers Look at Spravato’s Long-Term Use, Highlights Psychedelic Opportunity; MAHA Report Slams Psychiatric Meds; Momentum Builds for Beckley - Psychedelic Alpha

Earlier this month, a manuscript by Zaki et al. (2025) looked at the long-term safety and efficacy of esketamine nasal spray (Spravato) in treatment-resistant depression (TRD). It provides an unprecedented look at how the product is used over the medium and long term, such as average treatment duration, reasons for discontinuation, and outcomes. The data is derived… SourceRead Article

Psychedelics in Japan: Dr. Hiroyuki Uchida on Studies, Stigma, and the Road Ahead - Psychedelic Alpha

Editor’s Note: The following interview is published in both English and Japanese. To read the Japanese version, please scroll down (or click here).このインタビューは英語と日本語で公開されています。日本語を読みたい方は、スクロール（もしくはここをクリック）してください。 ∎ As global interest in the clinical use of psychedelic-based treatments continues to expand, Japan is beginning to carve its own path… SourcePsychedelic Drugs · JapanRead Article

Breaking News Topics Related to psychedelicalpha.com

Washington DC

Washington DC

Psychedelic Drugs

Psychedelic Drugs

Mental Health

Mental Health

Travis County

Travis County

United States

United States

News
For You
SearchBlindspotLocal